|
| |
| | | 68658 | | 07.06.2023 | | Sandoz Pharmaceuticals AG | | | | | | | 06.06.2028 | | | | | | 06.03.20. | | | | 06.03. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Dabigatran Sandoz 110 mg | Hartkapseln | Capsules (Dabigatranum Etexilatum 110 mg) | B01AE07 | CI | | 02 | Dabigatran Sandoz 150 mg | Hartkapseln | Capsules (Dabigatranum Etexilatum 150 mg) | B01AE07 | CI |
|
|
|
